Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...
13h
Stockhead on MSNCrucible: This rare blood disease tackler plans to hit investors with its best shotThe myelofibrosis drug landscape has become more crowded since Syntara decided to focus on the disease in 2020, but the ...
Newly released data from the phase 3 STOP-HS clinical trial program reveal positive results in hidradenitis suppurativa from ...
Povorcitinib is an oral Janus kinase 1 selective inhibitor that works to reduce the overactive inflammatory signaling pathway seen in HS.
20h
News-Medical.Net on MSNExperts release new guidelines on JAK inhibitors for chronic inflammatory diseasesJanus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as ...
While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...
Geron Corp's Rytelo launch & robust pipeline offer a compelling investment opportunity, despite stock challenges. Click here ...
With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.
The round of eight Stage in the Player Championship competition will feature the match between Neil Robertson vs Stuart ...
A Nintendo Switch 2 filing with the FCC has revealed the upcoming console may feature AI upscaling technology similar to ...
The voice actor for Aloy in Horizon Zero Dawn and Forbidden West has repsonded to the recently leaked video of an AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results